Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nourimanba
- Development stage
- Unknown
- Lead developer
- Zanmi Lasante
- Administration
- Oral
01
Overview
**Nourimanba** is a Haitian locally produced, peanut-based ready-to-use therapeutic food used to treat childhood malnutrition, particularly severe acute malnutrition. It is a high-calorie, high-protein paste formulated from peanuts, milk powder, vegetable oil, sugar, and a vitamin and mineral premix; its low water content permits storage without refrigeration and supports outpatient nutritional rehabilitation. The product is made in Haiti for distribution through the Zanmi Lasante and Partners In Health care network, with technical and facility-development support from Abbott. ([pih.org](https://www.pih.org/article/nourimanba-malnutrition-haiti-poverty))
- Brand names
- Nourimanba
- Other names
- Nourimamba
Beyond the preview
Go deeper on Nourimanba.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Nourimanba.